-transparent.png){kind=logo}
The authors compared ioversol 300 to iopamidol 300 by double blind study in patients undergoing enhanced computed body tomography. There was no significant difference in clinical tolerance and efficacy between the two products. Only minor reactions were recorded in both groups. Contrast media were not considered to be responsible for the poor diagnostic quality of a few explorations. Ioversol 300 appears as a well tolerated and effective contrast medium for computed body tomography.
Related Publications
C Chagnaud, and
G Moulin, and
L Delannoy, and
J Y Gaubert, and
D Haddad, and
J M Bartoli, and
M Kasbarian
June 1989,
Investigative radiology,
C Chagnaud, and
G Moulin, and
L Delannoy, and
J Y Gaubert, and
D Haddad, and
J M Bartoli, and
M Kasbarian
January 1992,
Annales de radiologie,
C Chagnaud, and
G Moulin, and
L Delannoy, and
J Y Gaubert, and
D Haddad, and
J M Bartoli, and
M Kasbarian
January 1992,
Annales de radiologie,
C Chagnaud, and
G Moulin, and
L Delannoy, and
J Y Gaubert, and
D Haddad, and
J M Bartoli, and
M Kasbarian
June 1989,
Investigative radiology,
C Chagnaud, and
G Moulin, and
L Delannoy, and
J Y Gaubert, and
D Haddad, and
J M Bartoli, and
M Kasbarian
January 1984,
Investigative radiology,
C Chagnaud, and
G Moulin, and
L Delannoy, and
J Y Gaubert, and
D Haddad, and
J M Bartoli, and
M Kasbarian
January 1992,
Annales de radiologie,
C Chagnaud, and
G Moulin, and
L Delannoy, and
J Y Gaubert, and
D Haddad, and
J M Bartoli, and
M Kasbarian
June 1989,
Investigative radiology,
C Chagnaud, and
G Moulin, and
L Delannoy, and
J Y Gaubert, and
D Haddad, and
J M Bartoli, and
M Kasbarian
January 1987,
Neuroradiology,
C Chagnaud, and
G Moulin, and
L Delannoy, and
J Y Gaubert, and
D Haddad, and
J M Bartoli, and
M Kasbarian
October 1984,
AJR. American journal of roentgenology,
C Chagnaud, and
G Moulin, and
L Delannoy, and
J Y Gaubert, and
D Haddad, and
J M Bartoli, and
M Kasbarian
January 1992,
Annales de radiologie,
